Video | Business Headlines | Internet | Science | Scientific Ethics | Technology | Search


Funding boost to test anti-cancer marine sponge

Significant new funding will help Victoria University scientists study the components of a special marine sponge that shows great promise as a potential anti-cancer agent.
A $99,200 one-year grant from the NZ Cancer Society has been awarded to the Bioactives Research team at the University. Drs Peter Northcote, John Hoberg, Paul Teesdale-Spittle and John Miller from Victoria’s Schools of Chemical & Physical Sciences and Biological Sciences will lead a team carrying out testing of peloruside on the suppression of cancerous tumour growth in vivo.

Peloruside, a molecule from sponges found only in New Zealand waters, was isolated and characterised by Victoria University’s Dr Peter Northcote in 2000. Since that time, scientists at Victoria have shown that peloruside prevents cell division by stabilising microtubules–the protein structures required for cell division–thus leading to the death of rapidly dividing cells. This action of peloruside is similar to that of Taxol®, an effective but expensive drug currently used in the treatment of breast, ovary, colon, liver, and lung cancer.

Dr Hoberg says that although still in relatively early stages of the research, there are already two potential advantages of peloruside over Taxol®. Tests around the world have shown that during treatment some cancer cells develop a resistance to Taxol®, necessitating the introduction of a new drug that will attack rapid cell growth. The second advantage of peloruside is that it is more water-soluble than Taxol®, making it easier to distribute through the bloodstream. Additionally, research by the Bioactives Research team has to date shown that peloruside appears to be as active as Taxol ®, which, along with its analogues, is estimated to have generated sales exceeding US$2billion.

To further develop peloruside as an anti-cancer agent, the Victoria University scientists are working with NIWA to culture the sponges that produce peloruside to provide a more stable natural source and protect the natural environment.

The team also aims to synthesise peloruside to provide an alternative source of supply, which also offers the potential for generating new molecules with even better activity than the natural product. Dr Hoberg hopes that synthetic peloruside will be ready for tests in about one year.

The peloruside research has also attracted funding from the Foundation for Science, Research & Technology and the Wellington Medical Research Foundation. The research is part of a wider programme involving the Schools of Chemical & Physical Sciences and Biological Sciences, aimed at developing strategies for an integrated approach in the search for anti-cancer, anti-inflammatory, and immunosuppressive drugs.


© Scoop Media

Business Headlines | Sci-Tech Headlines


Nurofen Promotion: Reckitt Benckiser To Plead Guilty To Misleading Ads

Reckitt Benckiser (New Zealand) intends to plead guilty to charges of misleading consumers over the way it promoted a range of Nurofen products, the Commerce Commission says. More>>


Half A Billion Accounts: Yahoo Confirms Huge Data Breach

The account information may have included names, email addresses, telephone numbers, dates of birth, hashed passwords (the vast majority with bcrypt) and, in some cases, encrypted or unencrypted security questions and answers. More>>

Rural Branches: Westpac To Close 19 Branches, ANZ Looks At 7

Westpac confirms it will close nineteen branches across the country; ANZ closes its Ngaruawahia branch and is consulting on plans to close six more branches; The bank workers union says many of its members are nervous about their futures and asking ... More>>

Interest Rates: RBNZ's Wheeler Keeps OCR At 2%

Reserve Bank governor Graeme Wheeler kept the official cash rate at 2 percent and said more easing will be needed to get inflation back within the target band. More>>


Half Full: Fonterra Raises Forecast Payout As Global Supply Shrinks

Fonterra Cooperative Group, the dairy processor which will announce annual earnings tomorrow, hiked its forecast payout to farmers by 50 cents per kilogram of milk solids as global supply continues to decline, helping prop up dairy prices. More>>



Meat Trade: Silver Fern Farms Gets Green Light For Shanghai Maling Deal

The government has given the green light for China's Shanghai Maling Aquarius to acquire half of Silver Fern Farms, New Zealand's biggest meat company, with ministers satisfied it will deliver "substantial and identifiable benefit". More>>


Get More From Scoop

Search Scoop  
Powered by Vodafone
NZ independent news